Stocktoria
JRSIS HEALTH CARE Corp JRSS
JRSIS HEALTH CARE Corp (JRSS) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2023 revenue was $3.5M at a -2.3% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -3.93 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
How it ranks in Services · percentile among 1013 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.208 |
| Retained earnings / assets | -1.605 |
| EBIT / assets | -0.088 |
| Equity / liabilities | -0.07 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| JRSS | JRSIS HEALTH CARE Corp | 6/9 | -7.26 | — | — |
| MD | Pediatrix Medical Group, Inc. | 6/9 | 2.05 | 12.3 | -4.9% |
| SEM | SELECT MEDICAL HOLDINGS CORP | 5/9 | 1.45 | 14 | +5.1% |
| EHC | Encompass Health Corp | 7/9 | — | 17.8 | +10.5% |
| GOOG | Alphabet Inc. | 5/9 | 6.79 | 31.1 | +15.1% |
| MSFT | MICROSOFT CORP | 6/9 | 4.59 | 20.7 | +17.8% |
| META | Meta Platforms, Inc. | 4/9 | 5.34 | 23.1 | +22.2% |
About JRSIS HEALTH CARE Corp
JRSIS Health Care Corporation develops and produces medical technology and equipment in the People's Republic of China. The company develops and markets a multi-faceted smart environment for the retail distribution of pharmaceutical products by pharmacies, hospitals, and online distributors. It offers JM-YF-2000 Automatic Medicine Dispenser, which provides intelligent prompts for high-speed facile human-computer interaction to yield prompt dispensing of medications and batch refilling in the user safety environment. The company was founded in 2018 and is based in Yongzhou, the People's Republic of China.
FAQ
Is JRSS financially healthy?
JRSIS HEALTH CARE Corp's Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does JRSS pay a dividend?
No, JRSIS HEALTH CARE Corp does not currently pay a dividend.
How profitable is JRSS?
In FY2023, JRSIS HEALTH CARE Corp had a net margin of -2.3%.
Is JRSS overvalued or undervalued?
JRSIS HEALTH CARE Corp trades at about 0.1× trailing earnings — below its 10-year norm (10-year range 9.3×–1039.7×, median 281.3×). Stocktoria reports the data, not buy/sell advice.
Is JRSS a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on JRSIS HEALTH CARE Corp: a Piotroski F-score of 6/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2023-12-31. Facts plus Stocktoria's own computed scores — not investment advice.